[Minutes, Advisory Committee to the Director GP-160 Meeting (1992: Bethesda, Maryland)]

169
1 drugs, and there are multiple symptoms. It's
2 long-term, three, four, five years of therapy. There
3 we have been able to handle these issues.
4 I just want to make one point that the
5 gentleman at the other end made. I forget your name,
6 sir. I think if you form this consortium of 300 or
7 400 centers around the country or in North America
8 that's capable of doing large, simple trials, say a
9 year down the road you've got a new therapy that looks
10 promising. You've got your infrastructure created to
11 answer your next question rapidly.
12 So in a sense, it will complement the
13 basic scientists and will lead to basic discoveries
14 rapidly being proven to be worthwhile or not
15 worthwhile, rather than waiting five, six, eight
16 years. So there is a sort of long-term perspective in
17 this as well.
18 CO-CHAIRMAN CARPENTER: Thank you, Dr.
19 Yusuf.
20 I think that Santiago has been waiting a
21 long time to comment.
22 DR. COREY: Could I make one quick

NEAL R. GROSS
COURT REPORTERS AND TRANSCRISERS
1323 RHODE ISLAND AVENUE, N.W.
[phone] WASHINGTON, D.C. 20005 [phone]